AbbVie is driving significant advancement in the treatment of pediatric HIV in poor countries by introducing two new medicines as part of a shared patent pool.
New smartphone camera-based technology works to improve medication adherence by capturing the patient take the medication, then analyzing data to ensure the patient took it correctly and sending an alert if they didn’t.
A startup has developed interactive 3D glasses for surgeons to wear in the operating room, allowing them to interact with patient records and anatomical models without removing their gloves.
Tests show positive results for a possible Ebola vaccine.
New artificial pancreas technology has shown successful results when compared to conventional pump therapy, though it won’t be available to market for several years.
-Amanda Kopec Preto, Manager, Strategic Marketing & Corporate Communications